Daily FNArena News

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

This final instalment on reporting season checks out the S in ESG in a season defined by labour shortages, fatalities, safety reporting, and same-job-same-pay developments; and psychosocial safety

A glance through the latest expert views and predictions about commodities: Morgan Stanley’s bullish outlook for aluminium & varying views by brokers on the outlook for copper

A-REITs have emerged as a compelling avenue for investors seeking regular streams of income with exposure to the real estate market without the complexities of physical property ownership. FNArena’s guide to investing in the sector

With Westpac’s FY24 earnings expected to continue to decline on stubbornly high costs, capital management provides support but will it last?

Michael Gable of Fairmont Equities notes that technically, the ASX200 has now put in a clear reversal

The ASX200 lost -3.8% in October with mid cap and small cap indices faring worse as 10-year bond yields climbed, while the gold price spiked

Tim Boreham highlights the success of Paradigm Biopharmaceuticals’ joint pain drug ahead of a capital raising

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments